Buy Bromonordiazepam Pellets 2.5mg

Product Overview

Bromonordiazepam Pellets 2.5mg represents a brandless, high-purity (≥98%) benzodiazepine analog designed exclusively for laboratory and analytical research. Classified as a reference material within the 1,4-benzodiazepine family, this compound supports advanced studies in analytical chemistry and forensic science. Researchers value its consistent formulation for applications requiring precise chemical standards, always within professional laboratory settings. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Chemical Identity & Classification

Bromonordiazepam carries the CAS number 2894-61-3 and features the molecular formula C15H11BrN2O, with a molecular weight of 315.16 g/mol. Known synonyms include 7-Bromo-5-phenyl-1,3-dihydro-2H-benzo[e]diazepin-2-one, Desalkylgidazepam, and 7-bromo-5-phenyl-1,2-dihydro-2H-1,4-benzodiazepin-2-one. This compound falls under the classification of analytical reagents and reference standards, particularly as a benzodiazepine metabolite analog for chromatographic and spectroscopic research.

Chemical & Physical Characteristics

Bromonordiazepam appears as an off-white to pale yellow crystalline solid, exhibiting a solid form suitable for pelletization. It demonstrates limited solubility in ethanol, with better performance in DMF (5 mg/mL) and DMSO (5 mg/mL), while showing low solubility in PBS (pH 7.2) at 0.12 mg/mL. Predicted physical data includes a melting point of 220-221°C (in ethyl ether), boiling point around 464.8°C, and density of approximately 1.51 g/cm³. Stability under standard laboratory conditions supports its use in controlled analytical protocols.

Purity & Analytical Verification

Each batch of Bromonordiazepam Pellets 2.5mg meets or exceeds 98% purity, verified through industry-standard methods such as High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Nuclear Magnetic Resonance (NMR), and Liquid Chromatography-Mass Spectrometry (LC-MS). These techniques ensure minimal impurities and batch-to-batch consistency, critical for reliable research outcomes. A detailed Certificate of Analysis (COA) accompanies every order, providing full chromatographic and spectroscopic data for researcher verification.

Quality Control & Batch Integrity

Production follows strict batch-controlled protocols, with each lot assigned unique traceability numbering from synthesis through packaging. Internal quality checks, supplemented by third-party testing, confirm purity, identity, and homogeneity prior to release. Comprehensive documentation, including raw material sourcing records and processing logs, ensures full accountability. This rigorous approach positions Bromonordiazepam Pellets 2.5mg as a dependable choice for laboratories demanding reproducible results.

Safety, Handling & Laboratory Precautions

Handle Bromonordiazepam Pellets 2.5mg in well-ventilated laboratory fume hoods, utilizing appropriate personal protective equipment (PPE) such as nitrile gloves, safety goggles, and lab coats. Trained personnel should conduct all manipulations in designated controlled environments to minimize exposure risks. Consult the accompanying Material Safety Data Sheet (MSDS/SDS) for detailed hazard classifications, storage incompatibilities, and spill response procedures.

Packaging, Labeling & Storage

Bromonordiazepam Pellets 2.5mg arrives in professional research-grade packaging featuring tamper-evident, moisture-resistant sealing to maintain integrity during transit. Labels comply with international standards, clearly displaying CAS 2894-61-3, batch number, purity level, and research-use designation. Store in a cool, dry place at room temperature (15-25°C), away from direct light and strong oxidizers, to preserve chemical stability over extended periods.

Intended Research Use & Market Positioning

This compound targets analytical chemistry, forensic toxicology, reference standard development, industrial R&D, and educational laboratory programs. Laboratories utilize Bromonordiazepam Pellets 2.5mg for method validation, calibration curves in LC-MS/GC-MS workflows, and stability studies of benzodiazepine analogs. Its precise pellet form facilitates accurate weighing and dissolution, enhancing efficiency in high-throughput research settings. Marketed exclusively to qualified institutions, it supports non-consumptive applications in controlled scientific investigations.

Ordering, Availability & Fulfillment

Bromonordiazepam Pellets 2.5mg remains in consistent stock for immediate fulfillment, with secure WooCommerce checkout processing orders around the clock. Discreet packaging ensures privacy, complemented by tracked international shipping and delivery confirmation. Responsive customer support handles inquiries on batch status, COA requests, and order tracking, facilitating seamless procurement for research operations.

Legal & Regulatory Disclaimer

Bromonordiazepam Pellets 2.5mg is sold strictly for research purposes only, not for human or veterinary use, clinical, diagnostic, or therapeutic applications. Buyers assume full responsibility for compliance with all applicable local, national, and international regulations governing research chemicals. Verify jurisdictional restrictions prior to purchase; this product ships exclusively to verified laboratory addresses. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.